Abstract
For many years a debate has raged over what constitutes futile medical care, if patients have a right to demand what doctors label as futile, and whether physicians should be obliged to provide treatments that they think are inappropriate. More recently, the argument has shifted away from the difficult project of definitions, to outlining institutional policies and procedures that take a measured and patient-by-patient approach to deciding if an existing or desired intervention is futile. The prototype is the Texas Advance Directives Act, but similar procedures have been widely implemented both with and without the protection of the law. While this method has much to recommend it, there are inherent moral flaws that have not received as much discussion as warranted. Because these strategies adopt a semblance of procedural justice, it is assumed that the outcomes of such proceedings will be both correct and fair. In this paper, I argue that there are three main irremediable defects in the policy approach: there is the potential for arbitrary decision-making about futility in specific cases; there are structural, pre-ordained consequences for ethnic minorities who would be disproportionately affected by the use of these procedures; and the use of rationing justifications to support the use of these policies. These flaws detract so much from any benefit that could be derived that they make such strategies more harmful than helpful.
Similar content being viewed by others
Notes
For a view from someone who is not a physician, see Katz (2011).
For a discussion of procedural justice, in both its impure and pure forms with its challenges, see Daniels and Sabin (2008, pp. 79–81) and Rawls (1999, pp. 74–78). The point that Rawls makes in his descriptions of perfect and imperfect pure procedural justice are extremely relevant to my criticism in this essay. It is assumed that a carefully considered and crafted procedure, such as TADA, will—if followed studiously—result in a just outcome, irrespective of the specificity of local circumstances of each case. The error in this assumption is that illustrated by Rawls in his example of a trial, in which the result that is hoped for (the truth) is not guaranteed even if all the rules are obeyed in punctilious fashion. One could qualify this wish by stating that so long as we get the truth (the right answer) almost all the time, then that is good enough (of course, this begs the question as where the cutoff should be between an acceptable and unacceptable level of mistakes).
This is concisely expressed in “Opinion 2.037—Medical Futility in End-of-Life Care”, available at http://www.ama-assn.org/ama/pub/physician-resources/medical-ethics/code-medical-ethics/opinion2037.page. Importantly, the last part opines that when all other efforts at dispute resolution have failed (including attempting to transfer the care for the patient to another physician or facility), “the intervention need not be offered”.
The main distinction is that the institution may go to court to attempt to have surrogate decision-makers removed on the grounds of making medically inappropriate decisions on behalf of the patient (Truog 2009a, b; Truog and Mitchell 2006; Brett 2005). For a discussion of some of the unresolved legal issues, see (Bissel 2010; O'Callaghan 2008).
The Johns Hopkins Hospital, Baltimore, MD.
Ironically, by virtue of their “special” treatment, VIPS may be subjected to substandard care in the misguided idea to provide them with the “very best” bedside management (i.e., the Chief of Medicine instead of the senior resident providing everyday care).
There has not been a detailed analysis of either the ethnicities of patients for whom TADA has been invoked or the possible effects of this law and its implementation on healthcare system trust in minority communities in Texas, mainly because the data does not exist. Interestingly, Dr. Fine, one of the original architects of TADA, has stated that there was concern about collecting demographic data mainly for these reasons, even though such results would not in and of itself be proof of discriminatory application of the law (R. Fine, personal communication).
For instance, this is the case at individual hospitals in North Carolina, Massachusetts and Maryland. I am grateful to Prof. Lance Stell and Drs. R. Truog and M. DeCamp for providing me with their hospital’s policies in this area.
See Callahan (2009). He calls this phenomenon “patient self-definition”.
References
Allen, L. A., Yager, J. E., Funk, M. J., Levy, W. C., Tulsky, J. A., Bowers, M. T., et al. (2008). Discordance between patient-predicted and model-predicted life expectancy among ambulatory patients with heart failure. Journal of the American Medical Association, 299(21), 2533–2542. doi:10.1001/jama.299.21.2533.
Alpers, A., & Lo, B. (1999). Avoiding family feuds: Responding to surrogate demands for life-sustaining interventions. The Journal of Law, Medicine & Ethics, 27(1), 74–80.
Anonymous. (1968). A definition of irreversible coma. Report of the Ad Hoc Committee of the Harvard Medical School to Examine the Definition of Brain Death. Journal of the American Medical Association, 205(6), 337–340.
Baily, M. A. (2011). Futility, autonomy, and cost in end-of-life care. The Journal of Law, Medicine & Ethics, 39(2), 172–182. doi:10.1111/j.1748-720X.2011.00586.x.
Bernat, J. L. (2005). Medical futility: Definition, determination, and disputes in critical care. Neurocritical Care, 2(2), 198–205.
Bernat, J. L. (2009). Brain death. In S. Laureys & G. Tononi (Eds.), The neurology of consciousness. Cognitive neuroscience and neuropathology (pp. 151–161). London: Academic Press.
Bissel, A. (2010). Order at the end of life: Establishing a clear and fair mechanism for the resolution of futility disputes. Vanderbilt Law Review, 63, 491–540.
Blackhall, L. J., Frank, G., Murphy, S. T., Michel, V., Palmer, J. M., & Azen, S. P. (1999). Ethnicity and attitudes towards life sustaining technology. Social Science and Medicine, 48(12), 1779–1789.
Boulware, L. E., Cooper, L. A., Ratner, L. E., LaVeist, T. A., & Powe, N. R. (2003). Race and trust in the health care system (research articles). Public Health Reports, 118(4), 358–365.
Brett, A. S. (2005). Futility revisited: Reflections on the perspectives of families, physicians, and institutions. HEC Forum, 17(4), 276–293. doi:10.1007/s10730-005-5154-y.
Burns, J. P., & Truog, R. D. (2007). Futility. Chest, 132(6), 1987–1993. doi:10.1378/chest.07-1441.
Callahan, D. (1998). False hopes. Why America’s quest for perfect health is a recipe for failure. New York: Simon and Shuster.
Callahan, D. (2009). Taming the beloved beast, chap. 6. Princeton: Princeton University Press.
Cohen, J., van Delden, J., Mortier, F., Lofmark, R., Norup, M., Cartwright, C., et al. (2008). Influence of physicians’ life stances on attitudes to end-of-life decisions and actual end-of-life decision-making in six countries. Journal of Medical Ethics, 34(4), 247–253.
Cruz-Flores, S., Rabinstein, A., Biller, J., Elkind, M. S., Griffith, P., Gorelick, P. B., et al. (2011). Racial-ethnic disparities in stroke care: The American experience: A statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke, 42(7), 2091–2116. doi:10.1161/STR.0b013e3182213e24.
Curlin, F. A., Lawrence, R. E., Chin, M. H., & Lantos, J. D. (2007a). Religion, conscience, and controversial clinical practices. New England Journal of Medicine, 356(6), 593–600.
Curlin, F. A., Sellergren, S. A., Lantos, J. D., & Chin, M. H. (2007b). Physicians’ observations and interpretations of the influence of religion and spirituality on health. Archives of Internal Medicine, 167(7), 649–654.
Daniels, N., & Sabin, J. (2008). Setting limits fairly. Learning to share resources for health (2nd ed.). Oxford: Oxford University Press.
Degenholtz, H. B., Thomas, S. B., & Miller, M. J. (2003). Race and the intensive care unit: Disparities and preferences for end-of-life care. Critical Care Medicine, 31(5 Suppl), S373–S378.
Diekema, D. S. (1996). The preferential treatment of VIPs in the emergency department. The American Journal of Emergency Medicine, 14(2), 226–229. doi:10.1016/S0735-6757(96)90137-0.
Fine, R. L. (2000). Medical futility and the Texas Advance Directives Act of 1999. Proceedings, 13(2), 144–147.
Fine, R. L. (2001). The Texas Advance Directives Act of 1999: Politics and reality. HEC Forum, 13(1), 59–81.
Fine, R. L. (2009). Point: The Texas Advance Directives Act effectively and ethically resolves disputes about medical futility. Chest, 136(4), 963–967. doi:10.1378/chest.09-1267.
Fine, R. L., & Mayo, T. W. (2003). Resolution of futility by due process: Early experience with the Texas Advance Directives Act. Annals of Internal Medicine, 138(9), 743–746.
Fox, R. C. (1957). Training for uncertainty. In R. K. Meron, G. G. Reader, & P. L. Kendall (Eds.), The student-physician (pp. 207–244). Cambridge, MA: Harvard University Press.
Gabbay, E., Calvo-Broce, J., Meyer, K., Trikalinos, T., Cohen, J., & Kent, D. (2010). The empirical basis for determinations of medical futility. Journal of General Internal Medicine, 25(10), 1083–1089. doi:10.1007/s11606-010-1445-3.
Galambos, C. M. (1998). Preserving end-of-life autonomy: The Patient Self-Determination Act and the Uniform Health Care Decisions Act. Health and Social Work, 23(4), 275–281.
Gampel, E. (2006). Does professional autonomy protect medical futility judgments? Bioethics, 20(2), 92–104.
Gregory, P. C., LaVeist, T. A., & Simpson, C. (2006). Racial disparities in access to cardiac rehabilitation (multicenter study). American Journal of Physical Medicine & Rehabilitation/Association of Academic Physiatrists, 85(9), 705–710. doi:10.1097/01.phm.0000233181.34999.3d.
Gust, D. A., Darling, N., Kennedy, A., & Schwartz, B. (2008). Parents with doubts about vaccines: Which vaccines and reasons why. Pediatrics, 122(4), 718–725. doi:10.1542/peds.2007-0538.
Guzman, J. A., Sasidhar, M., & Stoller, J. K. (2011). Caring for VIPs: Nine principles. Cleveland Clinic Journal of Medicine, 78(2), 90–94. doi:10.3949/ccjm.78a.10113.
Hakim, R. B., Teno, J. M., Harrell, F. E, Jr, Knaus, W. A., Wenger, N., Phillips, R. S., et al. (1996). Factors associated with do-not-resuscitate orders: Patients’ preferences, prognoses, and physicians’ judgments. SUPPORT investigators. Study to understand prognoses and preferences for outcomes and risks of treatment. Annals of Internal Medicine, 125(4), 284–293.
Halevy, A. (2008). Medical futility, patient autonomy, and professional integrity: Finding the appropriate balance (historical article). Health Matrix, 18(2), 261–290.
Halevy, A., & Brody, B. A. (1996). A multi-institution collaborative policy on medical futility. Journal of the American Medical Association, 276(7), 571–574. doi:10.1001/jama.1996.03540070067035.
Hanchate, A., Kronman, A. C., Young-Xu, Y., Ash, A. S., & Emanuel, E. (2009). Racial and ethnic differences in end-of-life costs: Why do minorities cost more than whites? Archives of Internal Medicine, 169(5), 493–501. doi:10.1001/archinternmed.2008.616.
Heilig, S., Andereck, W., Brody, R., Burns, P., Luce, J. M., Kennedy, W. K., et al. (1999). Nonbeneficial or futile medical treatment: Conflict resolution guidelines for the San Francisco Bay area. Bay Area Network of Ethics Committees (BANEC) Nonbeneficial Treatment Working Group. Western Journal of Medicine, 170(5), 287–290.
Heitman, E., & Gremillion, V. (2001). Ethics committees under Texas law: Effects of the Texas Advance Directives Act (evaluation studies). HEC Forum: An Interdisciplinary Journal on Hospitals’ Ethical and Legal Issues, 13(1), 82–104.
Helft, P. R., Siegler, M., & Lantos, J. (2000). The rise and fall of the futility movement. New England Journal of Medicine, 343(4), 293–296. doi:10.1056/NEJM200007273430411.
Hurst, S. A., Reiter-Theil, S., Slowther, A. M., Pegoraro, R., Forde, R., & Danis, M. (2008). Should ethics consultants help clinicians face scarcity in their practice? Journal of Medical Ethics, 34(4), 241–246. doi:10.1136/jme.2006.019828.
Jacobs, H. C. (2009). The Texas Advance Directives Act—is it a good model? Seminars in Perinatology, 33(6), 384–390. doi:10.1053/j.semperi.2009.07.006.
Jecker, N. S., & Schneiderman, L. J. (1992). Futility and rationing. American Journal of Medicine, 92(2), 189–196. doi:10.1016/0002-9343(92)90111-n.
Johnson, K. S., Kuchibhatla, M., & Tulsky, J. A. (2008). What explains racial differences in the use of advance directives and attitudes toward hospice care? (research support, N.I.H., Extramural). Journal of the American Geriatrics Society, 56(10), 1953–1958. doi:10.1111/j.1532-5415.2008.01919.x.
Johnson, R. W., Newby, L. K., Granger, C. B., Cook, W. A., Peterson, E. D., Echols, M., et al. (2010). Differences in level of care at the end of life according to race. American Journal of Critical Care, 19(4), 335–343. doi:10.4037/ajcc2010161.
Kagawa-Singer, M., & Blackhall, L. J. (2001). Negotiating cross-cultural issues at the end of life: “You got to go where he lives”. JAMA, 286(23), 2993–3001.
Katz, M. (2011). When is medical care “futile”? The institutional competence of the medical profession regarding the provision of life = sustaining care. Nebraska Law Review, 90, 1–69.
Lantos, J. (2006). When parents request seemingly futile treatment for their children. Mount Sinai Journal of Medicine, 73(3), 587–589.
Lantos, J. D., Singer, P. A., Walker, R. M., Gramelspacher, G. P., Shapiro, G. R., Sanchez-Gonzalez, M. A., et al. (1989). The illusion of futility in clinical practice. American Journal of Medicine, 87(1), 81–84.
Larochelle, M. R., Rodriguez, K. L., Arnold, R. M., & Barnato, A. E. (2009). Hospital staff attributions of the causes of physician variation in end-of-life treatment intensity (multicenter study research support, N.I.H., Extramural). Palliative Medicine, 23(5), 460–470. doi:10.1177/0269216309103664.
Melichar, L. (2009). The effect of reimbursement on medical decision making: Do physicians alter treatment in response to a managed care incentive? Journal of Health Economics, 28(4), 902–907. doi:10.1016/j.jhealeco.2009.03.004.
Montgomery, K. (2006). How doctors think. New York: Oxford University Press.
Moratti, S. (2009). The development of “medical futility”: Towards a procedural approach based on the role of the medical profession. Journal of Medical Ethics, 35(6), 369–372. doi:10.1136/jme.2008.027755.
Morrison, R. S., & Meier, D. E. (2004). High rates of advance care planning in New York City’s elderly population (clinical trial randomized controlled trial research support, non-U.S. Gov’t research support, U.S. Gov’t, P.H.S.). Archives of Internal Medicine, 164(22), 2421–2426. doi:10.1001/archinte.164.22.2421.
Moseley, K. L., Church, A., Hempel, B., Yuan, H., Goold, S. D., & Freed, G. L. (2004). End-of-life choices for African-American and white infants in a neonatal intensive-care unit: A pilot study. Journal of the National Medical Association, 96(7), 933–937.
Moylan, C. A., Brady, C. W., Johnson, J. L., Smith, A. D., Tuttle-Newhall, J. E., & Muir, A. J. (2008). Disparities in liver transplantation before and after introduction of the MELD score. JAMA, 300(20), 2371–2378.
Muni, S., Engelberg, R. A., Treece, P. D., Dotolo, D., & Curtis, J. R. (2011). The influence of race/ethnicity and socioeconomic status on end-of-life care in the ICU. Chest, 139(5), 1025–1033. doi:10.1378/chest.10-3011.
O’Callaghan, N. (2008). When Atlas shrugged: May the state wash its hands of those in need of life-sustaining medical treatment? Health Matrix, 18, 291–372.
Okhuysen-Cawley, R., McPherson, M. L., & Jefferson, L. S. (2007). Institutional policies on determination of medically inappropriate interventions: Use in five pediatric patients. Pediatric Critical Care Medicine, 8(3), 225–230. doi:10.1097/01.PCC.0000264317.83788.ED.
Pellegrino, E. D. (2005). Futility in medical decisions: The word and the concept. HEC Forum, 17(4), 308–318. doi:10.1007/s10730-005-5156-9.
Poses, R. M., Bekes, C., Copare, F. J., & Scott, W. E. (1989). The answer to “What are my chances, Doctor?” depends on whom is asked: Prognostic disagreement and inaccuracy for critically ill patients. Critical Care Medicine, 17(8), 827–833.
Poses, R. M., McClish, D. K., Bekes, C., Scott, W. E., & Morley, J. N. (1991). Ego bias, reverse ego bias, and physicians’ prognostic. Critical Care Medicine, 19(12), 1533–1539.
Prendergast, T. J. (1995). Futility and the common cold. Chest, 107(3), 836–844. doi:10.1378/chest.107.3.836.
President’s Council on Bioethics. (2008). Controversies in the determination of death. Washington, D.C.: Department of Health and Human Services.
Rajakumar, K., Thomas, S. B., Musa, D., Almario, D., & Garza, M. A. (2009). Racial differences in parents’ distrust of medicine and research (comparative study research support, N.I.H., Extramural). Archives of Pediatrics and Adolescent Medicine, 163(2), 108–114. doi:10.1001/archpediatrics.2008.521.
Rawls, J. (1999). A theory of justice (revised ed.). Cambridge, MA: Harvard University Press.
Rosoff, P. M., & Coleman, D. L. (2011). The case for legal regulation of physicians’ off-label prescribing. Notre Dame Law Review, 86(2), 649–691.
Schneiderman, L. J., Jecker, N. S., & Jonsen, A. R. (1990). Medical futility: Its meaning and ethical implications. Annals of Internal Medicine, 112(12), 949–954. doi:10.1059/0003-4819-112-12-949.
Schneiderman, L. J., Jecker, N. S., & Jonsen, A. R. (1996). Medical futility: Response to critiques. Annals of Internal Medicine, 125(8), 669–674. doi:10.1059/0003-4819-125-8-199610150-00007.
Shafrin, J. (2010). Operating on commission: Analyzing how physician financial incentives affect surgery rates (comparative study). Health Economics, 19(5), 562–580. doi:10.1002/hec.1495.
Silveira, M. J., Kim, S. Y. H., & Langa, K. M. (2010). Advance directives and outcomes of surrogate decision making before death. New England Journal of Medicine, 362(13), 1211–1218. doi:10.1056/NEJMsa0907901.
Smally, A. J., Carroll, B., Carius, M., Tilden, F., & Werdmann, M. (2011). Treatment of VIPs. Annals of Emergency Medicine, 58(4), 397–398. doi:10.1016/j.annemergmed.2011.05.009.
Smith, M. L. (2008). Medical inappropriateness review: Appropriately performed by a medical committee. Health Matrix: Journal of Law-Medicine, 18(2), 237–244.
Smith, M. L., Gremillion, G., Slomka, J., & Warneke, C. L. (2007). Texas hospitals’ experience with the Texas Advance Directives Act. Critical Care Medicine, 35(5), 1271–1276.
Stewart, C. (2011). Futility determination as a process: Problems with medical sovereignty, legal issues and the strengths and weakness of the procedural approach. Journal of Bioethical Inquiry, 8(2), 155–163. doi:10.1007/s11673-011-9297-z.
Truog, R. D. (2000). Futility in pediatrics: From case to policy. Journal of Clinical Ethics, 11(2), 136–141.
Truog, R. D. (2007). Brain death—too flawed to endure, too ingrained to abandon. Journal of Law, Medicine & Ethics, 35(2), 273–281.
Truog, R. D. (2008). End-of-life decision-making in the United States. European Journal of Anaesthesiology, 25(Supplement S42), 43–50. doi:10.1017/S0265021507003419.
Truog, R. D. (2009a). Counterpoint: The Texas Advance Directives Act is ethically flawed. Chest, 136(4), 968–971. doi:10.1378/chest.09-1269.
Truog, R. D. (2009). Counterpoint: The Texas Advance Directives Act is ethically flawed: Medical futility disputes must be resolved by a fair process (comment comparative study). Chest, 136(4), 968–971; discussion 971–963. doi:10.1378/chest.09-1269.
Truog, R. D., & Mitchell, C. (2006). Futility—from hospital policies to state laws. American Journal of Bioethics, 6(5), 19–21; discussion W30-12. doi:10.1080/15265160600858989.
Tversky, A., & Kahneman, D. (1974). Judgment under uncertainty: Heuristics and biases. Science, 185(4157), 1124–1131.
Ubel, P. A. (2001). Pricing life. Why it’s time for health care rationing. Cambridge, MA: MIT Press.
Ubel, P. A., & Goold, S. (1997). Recognizing bedside rationing: Clear cases and tough calls. Annals of Internal Medicine, 126(1), 74–80.
Vig, E., Starks, H., Taylor, J., Hopley, E., & Fryer-Edwards, K. (2007). Surviving surrogate decision-making: What helps and hampers the experience of making medical decisions for others. Journal of General Internal Medicine, 22(9), 1274–1279. doi:10.1007/s11606-007-0252-y.
Volandes, A. E., Paasche-Orlow, M., Gillick, M. R., Cook, E. F., Shaykevich, S., Abbo, E. D., et al. (2008). Health literacy not race predicts end-of-life care preferences. Journal of Palliative Medicine, 11(5), 754–762.
Waters, C. M. (2001). Understanding and supporting African Americans’ perspectives of end-of-life care planning and decision making. Qualitative Health Research, 11(3), 385–398.
White, D. B., Engelberg, R. A., Wenrich, M. D., Lo, B., & Curtis, J. R. (2010). The language of prognostication in intensive care units. Medical Decision Making, 30(1), 76–83. doi:10.1177/0272989x08317012.
Wijdicks, E. F. (2001). The diagnosis of brain death. New England Journal of Medicine, 344(16), 1215–1221.
Wilkinson, D. (2009). The self-fulfilling prophecy in intensive care. Theoretical Medicine and Bioethics, 30(6), 401–410. doi:10.1007/s11017-009-9120-6.
Wojtasiewicz, M. E. (2006). Damage compounded: Disparities, distrust, and disparate impact in end-of-life conflict resolution policies. American Journal of Bioethics, 6(5), 8–12. doi:10.1080/15265160600856801.
Zier, L. S., Burack, J. H., Micco, G., Chipman, A. K., Frank, J. A., Luce, J. M., et al. (2008). Doubt and belief in physicians’ ability to prognosticate during critical illness: The perspective of surrogate decision makers. Critical Care Medicine, 36(8), 2341–2347. doi:10.1097/CCM.0b013e318180ddf9.
Zimrin, A. B., & Hess, J. R. (2007). Planning for pandemic influenza: Effect of a pandemic on the supply and demand for blood products in the United States. Transfusion, 47(6), 1071–1079.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Rosoff, P.M. Institutional Futility Policies are Inherently Unfair. HEC Forum 25, 191–209 (2013). https://doi.org/10.1007/s10730-012-9194-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10730-012-9194-9